167 related articles for article (PubMed ID: 7137978)
1. [Acute toxic action of combinations of antibiotics with isoniazid].
Ziia AV; Sokolova GB; Lebedeva MN
Antibiotiki; 1982; 27(7):535-9. PubMed ID: 7137978
[TBL] [Abstract][Full Text] [Related]
2. Subchronic toxicity of human immunodeficiency virus and tuberculosis combination therapies in B6C3F1 mice.
Rao GN; Lindamood C; Heath JE; Farnell DR; Giles HD
Toxicol Sci; 1998 Sep; 45(1):113-27. PubMed ID: 9848118
[TBL] [Abstract][Full Text] [Related]
3. Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis.
Kradolfer F; Schnell R
Arzneimittelforschung; 1973 Oct; 23(10):1462-4. PubMed ID: 4591314
[No Abstract] [Full Text] [Related]
4. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
Bondarev IM; Ivanov VL; Novoselova VP; Kovaleva LA; Shtegel'man LA
Antibiotiki; 1984 Jun; 29(6):430-4. PubMed ID: 6476805
[TBL] [Abstract][Full Text] [Related]
5. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
González Montaner LJ; Palma Beltrán O; Abbate E; Dambrosi A; Mosca C
Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
[No Abstract] [Full Text] [Related]
6. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
Titarenko OT; Vakhmistrova TI; Perova TL
Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
[TBL] [Abstract][Full Text] [Related]
7. Influence of immunosuppression on the action of antimycobacterial drugs in experimental tuberculosis. I. Effects of isoniazid, rifampicin and streptomycin on the survival of tuberculous mice immunosuppressed by azathioprine (Imuran).
Trnka L; Kvapilová M; Mison P
Chemotherapy; 1976; 22(6):353-61. PubMed ID: 954481
[TBL] [Abstract][Full Text] [Related]
8. [Hepatotoxic effect of a combination of pyrazinamide with isoniazid and rifampicin].
Slivka IuI; Klimniuk EV; Tabachuk OE
Probl Tuberk; 1989; (4):39-42. PubMed ID: 2734263
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules.
Zwolska Z; Niemirowska-Mikulska H; Augustynowicz-Kopec E; Walkiewicz R; Stambrowska H; Safianowska A; Grubek-Jaworska H
Int J Tuberc Lung Dis; 1998 Oct; 2(10):824-30. PubMed ID: 9783530
[TBL] [Abstract][Full Text] [Related]
11. [Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol].
Skakun NP; Tabachuk OE
Probl Tuberk; 1991; (10):77-9. PubMed ID: 1788241
[TBL] [Abstract][Full Text] [Related]
12. [Rifomycin in continuous and intermittent combined treatment of experimental tuberculosis in mice].
Grumbach F
Acta Tuberc Pneumol Belg; 1969; 60(3):390-6. PubMed ID: 5371670
[No Abstract] [Full Text] [Related]
13. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
14. [Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse].
Truffot-Pernot C; Grosset J; Bismuth R; Lecoeur H
Rev Fr Mal Respir; 1983; 11(6):875-82. PubMed ID: 6669798
[TBL] [Abstract][Full Text] [Related]
15. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
16. [Hepato-biliary effect of the rifomycin-isoniazid combination. II. Histological study on tuberculized mice].
Balea T; Marche C; Marche J
Therapie; 1970; 25(1):125-30. PubMed ID: 5436794
[No Abstract] [Full Text] [Related]
17. [Glycolysis components and carbohydrate metabolic enzyme activity of the blood under long-term action of rifampicin and isoniazid].
Khomenko AG; Vysochina IV; Efimova LN; Kuz'mina NV
Biull Eksp Biol Med; 1982 Apr; 93(4):54-7. PubMed ID: 7082803
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
Panchagnula R; Singh I; Kaur KJ; Kaul CL
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):625-8. PubMed ID: 10669909
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study of the toxic effect of combinations of tobramycin and carbenicillin].
Iakushkina IV; Filippos'iants ST; Shevniuk LA
Antibiotiki; 1984 May; 29(5):361-5. PubMed ID: 6742807
[TBL] [Abstract][Full Text] [Related]
20. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
